Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

VEEA vs TNON: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

VEEA Wins Head-to-Head Institutional Verdict (3–1 across 6 Pillars · 6–2 Matrix Metrics)

VEEA Overall Winner 6-Pillar Tally: VEEA 3 – 1 TNON (2 Tie) Matrix Metrics: VEEA 6 – 2 TNON

As of Nov 16, 2026, Veea Inc. (VEEA) is the stronger overall head-to-head candidate over Tenon Medical, Inc. (TNON) in the Tradestie Institutional Equity Comparison Engine, winning 6–2 core matrix metrics and 3–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). VEEA carries a Unified Composite Score of 47.7/100 (HOLD) at $4.78 (N/M Forward P/E, -3873.7% operating margin), whereas TNON carries 41.0/100 (SELL) at $1.33 (N/M Forward P/E, -228.0% operating margin).

  • Technical & Structure Timing Caution: VEEA trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 53.1); meanwhile TNON is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 27.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About VEEA vs TNON
VEEA NASDAQ Head-to-Head Winner
Veea Inc. Common Stock
Services-Computer Integrated Systems Design
$4.78
+6.46% 1D
Market Cap $18.3M
TTM Revenue $491,488
Forward P/E N/M
Beta / 30D Vol -2.32β · 136% Vol
Unified Composite Score
47.7 / 100 HOLD
Tech 40.0 Fund 48.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (67.3% over 20 days), RSI 53
RSI-14: 53.1 · SMA20: $4.73 · SMA50: $4.18
TNON NASDAQ
Tenon Medical, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$1.33
-5.32% 1D
Market Cap $3.8M
TTM Revenue $5.3M
Forward P/E N/M
Beta / 30D Vol -1.54β · 106% Vol
Unified Composite Score
41.0 / 100 SELL
Tech 25.0 Fund 43.0 Flow 50.0 Mom 55.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -33.3%), weak momentum, RSI 28
RSI-14: 27.7 · SMA20: $1.96 · SMA50: $2.95

6-Pillar Scorecard Institutional Category Breakdown (VEEA 3 – 1 TNON)

Columns: Metric · VEEA · TNON
1. Valuation Multiples TNON
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue 62.7x 1.5x
2. Growth & Scale VEEA
Revenue Growth (YoY) +141.6% +126.8%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) $491,488 $5.3M
Market Cap $18.3M $3.8M
3. Profitability & Quality VEEA
Gross Margin 74.3% 66.8%
Operating Margin -3873.7% -228.0%
Net Profit Margin 0.0% -257.9%
Return on Equity (ROE) 0.0% -551.2%
4. Balance Sheet & Cash Flow VEEA
Cash Generation (TTM) -$19M -$12M EBITDA
Cash Flow Margin N/A N/A
Net Cash / Leverage $13M Net Debt (1.67x D/E) $4.0M Net Debt
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markup NEUTRAL · Markdown
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Information Technology Services Operator Medical Devices Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: VEEA (6) vs TNON (2)
Institutional Metric VEEA TNON Criterion Row Edge
Market Capitalization
Scale
$18.3M $3.8M Larger Scale VEEA
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
+141.6% +126.8% Higher Growth VEEA
Operating Margin (TTM)
Profitability
-3873.7% -228.0% Higher Margin TNON
Net Profit Margin
Profitability
0.0% -257.9% Higher Margin VEEA
Return on Equity (ROE)
Capital Efficiency
0.0% -551.2% Higher ROE VEEA
52-Week Range Position
Momentum
53% ($0–$9) 7% ($0–$18) Stronger Trend VEEA
Beta / 30D Volatility
Risk Regime
-2.32β · 136% Vol -1.54β · 106% Vol Lower Realized Risk TNON
Unified Institutional Score
Composite Signal
47.7 / 100 (HOLD) 41.0 / 100 (SELL) Higher Composite VEEA
Trailing 12M Revenue (USD)
Operating Scale
$491,488 $5.3M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
74.3% 66.8% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 62.7x EV/Rev N/M PEG · 1.5x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$19M ($13M Net Debt (1.67x D/E)) -$12M EBITDA ($4.0M Net Debt) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon VEEA +64.1 pp
VEEA: +13.54% · TNON: -50.56%
3M Horizon VEEA +3416.82 pp
VEEA: +3341.32% · TNON: -75.5%
6M Horizon VEEA +607.74 pp
VEEA: +701.61% · TNON: +93.87%
1Y Horizon VEEA +723.26 pp
VEEA: +736.4% · TNON: +13.14%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period VEEA Revenue TNON Revenue VEEA Op. Margin TNON Op. Margin Margin Leader
FY2021 N/A $0M N/A -4038.1% TNON
FY2022 N/A $0M N/A -2709.8% TNON
FY2023 $10M $0M -114.2% -537.1% VEEA
FY2024 $0M $0M -59309.8% -420.1% TNON
FY2025 $0M $0M -8483.7% -324.3% TNON

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
VEEA UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact VEEA Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
TNON UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact TNON Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
VEEA Moat Profile Cyclical / Execution-Driven Positioning
Information Technology Services Operator
Competes within the Information Technology Services value chain with $18.3M market capitalization and -3873.7% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
TNON Moat Profile Cyclical / Execution-Driven Positioning
Medical Devices Operator
Competes within the Medical Devices value chain with $3.8M market capitalization and -228.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ VEEA vs TNON Key Questions & Quantitative Answers

As of Nov 16, 2026, Veea Inc. (VEEA) is the stronger overall head-to-head candidate over Tenon Medical, Inc. (TNON) in the Tradestie Institutional Equity Comparison Engine, winning 6–2 core matrix metrics and 3–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). VEEA carries a Unified Composite Score of 47.7/100 (HOLD) at $4.78 (N/M Forward P/E, -3873.7% operating margin), whereas TNON carries 41.0/100 (SELL) at $1.33 (N/M Forward P/E, -228.0% operating margin). Technical & Structure Timing Caution: VEEA trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 53.1); meanwhile TNON is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 27.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

VEEA leads the Growth & Scale pillar: VEEA posts +141.6% YoY revenue growth and +0.0% YoY earnings growth on $491,488 TTM revenue (74.3% gross margin, -3873.7% operating margin), compared with TNON at +126.8% YoY revenue growth and +0.0% YoY earnings growth on $5.3M TTM revenue (66.8% gross margin, -228.0% operating margin). Across the 5-period historical trajectory (FY2021 to FY2025), VEEA cumulative revenue shifted N/A while TNON shifted N/A. In operating R&D and SG&A reinvestment, VEEA deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for TNON.

TNON screens cheaper on headline valuation multiples. VEEA trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 62.7x EV/Revenue (unreported FCF margin), whereas TNON trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 1.5x EV/Revenue (unreported EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against VEEA (0.0% ROE) versus TNON (-551.2% ROE) capital efficiency.

In options market volatility and institutional positioning, VEEA carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-2.32β · 136% Vol realized risk). By comparison, TNON carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-1.54β · 106% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.